47 related articles for article (PubMed ID: 32173978)
41. Role of common ERCC1 polymorphisms in cisplatin-resistant epithelial ovarian cancer patients: A study in Chinese cohort.
Bao Y; Yang B; Zhao J; Shen S; Gao J
Int J Immunogenet; 2020 Oct; 47(5):443-453. PubMed ID: 32173978
[TBL] [Abstract][Full Text] [Related]
42. Association studies of ERCC1 polymorphisms with lung cancer susceptibility: a systematic review and meta-analysis.
Zhu J; Hua RX; Jiang J; Zhao LQ; Sun X; Luan J; Lang Y; Sun Y; Shang K; Peng S; Ma J
PLoS One; 2014; 9(5):e97616. PubMed ID: 24841208
[TBL] [Abstract][Full Text] [Related]
43. Association of ERCC1 Polymorphisms with the Risk of Colorectal Cancer: A Meta-Analysis.
Chen J; Sun N; Hu G; Chen X; Jiang J; Wu H; Luo G
Crit Rev Eukaryot Gene Expr; 2017; 27(3):267-275. PubMed ID: 29199611
[TBL] [Abstract][Full Text] [Related]
44. Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk.
Zhou CX; Zhao JH
Genet Mol Res; 2015 Mar; 14(1):2868-75. PubMed ID: 25867436
[TBL] [Abstract][Full Text] [Related]
45. Relationship between ERCC1 and XPC polymorphisms and the susceptibility to head and neck carcinoma: A systematic review, meta-analysis, and trial sequential analysis.
Imani MM; Akbari S; Shalchi M; Sadeghi E; Sadeghi M
Arch Oral Biol; 2024 Jun; 162():105955. PubMed ID: 38479279
[TBL] [Abstract][Full Text] [Related]
46. Common Genetic Variation and Susceptibility to Ovarian Cancer: Current Insights and Future Directions.
Kar SP; Berchuck A; Gayther SA; Goode EL; Moysich KB; Pearce CL; Ramus SJ; Schildkraut JM; Sellers TA; Pharoah PDP
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):395-404. PubMed ID: 28615364
[TBL] [Abstract][Full Text] [Related]
47.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]